Statistics for Adaptive Biotechnologies (id:7739 ADPT)

Valuation metrics

Market cap

749.70M

Enterprise value

730.70M

Trailing P/E (ttm)

-3.01

Forward P/E

-5.40

PEG ratio

-5.40

Price/Sales (ttm)

4.23

Price/Book (mrq)

3.35

Enterprise Value/Revenue

4.12

Enterprise Value/EBITDA

-4.97

Overview

Shares outstanding

147.58M

Float

76.80M

Shares short

8.96M

% Held by insiders

0.02%

% Held by institutions

0.94%

Average volume (10 days)

1.28M

Average volume (90 days)

Price summary

52-Week low

2.28

52-Week high

6.70

52-Week change

7.68%

Beta

1.45

50-Day moving average

4.95

200-Day moving average

3.98

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-110.13%

Operating margin

-70.28%

Operational effectiveness

Return on assets

-16.37%

Return on equity

-66.76%

Income statement

Revenue (ttm)

1.21

Revenue per share (ttm)

1.21

Quarterly revenue growth (yoy)

Gross profit (ttm)

94.72M

EBITDA

-146,946,000.00

Net income to common (ttm)

-195,240,992.00

Diluted EPS (ttm)

-1.34

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

243.33M

Total cash per share (mrq)

1.65

Total debt (mrq)

224.52M

Total Debt/Equity (mrq)

100.42

Current ratio (mrq)

351.90%

Book value per share (mrq)

1.52

Cash flow

Cash flow statement

-109,653,000.00

Levered free cash flow (LFCF)

-44,016,248.00